Related Experiment Videos
Urinary tract infections treated with single dose of short-acting sulphonamide
Abstract:
In a prospective study 29 patients with urinary tract infections caused by sulphonamide-sensitive organisms were treated with a single oral dose of the short-acting sulphonamide sulphafurazole. Twenty-seven (93%) of the 29 patients--and possibly all 29--were cured of their infections. There was no difference in the recurrence rates after single-dose treatment and treatment for 10 days or more. Six out of eight strains of Escherichia coli causing early recurrences were sensitive to sulphonamides. These results suggest that uncomplicated infections may safely and successfully be treated by a single oral dose of a short-acting sulphonamide.
Insights
A single oral dose of sulphafurazole effectively treated most urinary tract infections (UTIs) caused by sensitive bacteria. This short-acting sulfonamide showed comparable recurrence rates to longer treatments, suggesting safe and successful single-dose UTI therapy.
Area of Science:
- Pharmacology
- Infectious Diseases
- Urology
Background:
- Urinary tract infections (UTIs) are common bacterial infections.
- Sulfonamides are a class of antibiotics used to treat bacterial infections.
Purpose of the Study:
- To evaluate the efficacy and recurrence rates of a single oral dose of sulphafurazole for treating UTIs.
- To compare single-dose sulphafurazole treatment with conventional longer-duration regimens.
Main Methods:
- Prospective study involving 29 patients with UTIs caused by sulfonamide-sensitive organisms.
- Treatment administered as a single oral dose of the short-acting sulfonamide, sulphafurazole.
- Recurrence rates were monitored and compared between single-dose and longer treatment durations.
Main Results:
- A cure rate of 93% (27 out of 29 patients) was observed with single-dose sulphafurazole.
- No significant difference in recurrence rates was found between single-dose and conventional (10+ days) treatment.
- Escherichia coli strains causing early recurrences remained sensitive to sulfonamides.
Conclusions:
- Single oral dose of short-acting sulphafurazole is a safe and effective treatment for uncomplicated UTIs.
- Single-dose therapy offers a viable alternative to longer treatment durations for UTIs.
- The study supports the use of single-dose sulphafurazole for uncomplicated urinary tract infections.